MétaCan
Menu
Back to cohort
Record W4412647992 · doi:10.1016/s2213-8587(25)00405-x

Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries

2025· preprint· en· W4412647992 on OpenAlexaff
Alicia Huerta‐Chagoya, Joohyun Kim, Ravi Mandla, Yingchang Lu, Ken Suzuki, Lauren E. Petty, Hong Kiat Ng, Jaewon Choi, Simon Lee, Madhusmita Rout, Kuang Lin, Linda S. Adair, Adebowale Adeyemo, Habibul Ahsan, Masato Akiyama, Ping An, Sonia S. Anand, Diane M. Becker, Alain G. Bertoni, Zheng Bian, Lawrence F. Bielak, John Blangero, Michael Boehnke, Erwin P. Böttinger, Donald W. Bowden, Fiona Bragg, Jennifer A. Brody, Thomas A. Buchanan, Brian E. Cade, Jin Fang Chai, John C. Chambers, Giriraj R. Chandak, Li-Ching Chang, Kyong‐Mi Chang, Miao-Li Chee, Chien-Hsiun Chen, Yuan-Tsong Chen, Zhengming Chen, Yii‐Der Ida Chen, Jihua Chen, Guanjie Chen, Shyh‐Huei Chen, Wei‐Min Chen, Ching‐Yu Cheng, Yoon Shin Cho, Hyeok Sun Choi, Lee‐Ming Chuang, Miguel Cruz, Mary Cushman, Swapan K. Das, Ralph A. DeFronzo, H Janaka deSilva, Latchezar Dimitrov, Ayo P. Doumatey, Shufa Du, Qing Duan, Ravindranath Duggirala, Leslie S. Emery, James C. Engert, Daniel S. Evans, Michele K. Evans, Sarah Finer, José C. Florez, James S. Floyd, Myriam Fornage, Eitan Frankel, Barry I. Freedman, Lourdes García‐García, Pauline Genter, Hertzel C. Gerstein, Mark O. Goodarzi, Penny Gordon‐Larsen, Mariaelisa Graff, Myron Gross, Canqing Yu, Xiuqing Guo, Yang Hai, Craig L. Hanis, M. Geoffrey Hayes, Momoko Horikoshi, Annie-Green Howard, Sarah Hsu, Willa A. Hsueh, Wei Huang, Mengna Huang, Yi‐Jen Hung, Mi Yeong Hwang, Chii‐Min Hwu, Sahoko Ichihara, Michiya Igase, Eli Ipp, Mohammad Tariqul Islam, Masato Isono, Hye-Mi Jang, Farzana Jasmine, Jost B. Jonas, Yoonjung Yoonie Joo, Edmond K. Kabagambe, Takashi Kadowaki, Fouad Kandeel, Sharon L. R. Kardia, Elizabeth W. Karlson, Anuradhani Kasturiratne, Norihiro Kato, Tomohiro Katsuya, Varinderpal Kaur, Takahisa Kawaguchi, Jacob M. Keaton, Abel Kho, Chiea Chuen Khor, Muhammad G. Kibriya, Bong-Jo Kim, Woon-Puay Koh, Katsuhiko Kohara, Jaspal S. Kooner, Charles Kooperberg, Raymond J. Kreienkamp, Amel Lamri, Leslie A. Lange, Nanette R. Lee, Myung‐Shik Lee, Jung‐Jin Lee, Donna M. Lehman, Liming Li, Yun Li, Victor JY Lim, Jianjun Liu, Yongmei Liu, Simin Liu, Jirong Long, Tin Louie, Xi Luo, Jun Lv, Julie A. Lynch, Shiro Maeda, Anubha Mahajan, Nisa M. Maruthur, Fumihiko Matsuda, Mark I. McCarthy, Roberta McKean‐Cowdin, James B. Meigs, Iona Y. Millwood, Ayesha A. Motala, Girish N. Nadkarni, Jerry L. Nadler, Masahiro Nakatochi, Mike A. Nalls, Uma Nayak, Aude Nicolas, Kari E. North, Darryl Nousome, Yukinori Okada, Ian Pan, James S. Pankow, Guillaume Paré, Jae‐Hyun Park, Kyong Soo Park, Esteban J. Parra, Sanjay R. Patel, Mark A. Pereira, Patricia A. Peyser, Fraser Pirie, Michael Preuß, Michael A. Province, Bruce M. Psaty, Leslie J. Raffel, Laura M. Raffield, Laura J. Rasmussen‐Torvik, Susan Redline, Alexander P. Reiner, Stephen S. Rich, Rebecca Rohde, Kathryn Roll, Rashedeh Roshani, Charles N. Rotimi, Charumathi Sabanayagam, Danish Saleheen, Kevin Sandow, Claudia Schurmann, Hasan Shahriar, Douglas M. Shaw, Wayne Huey‐Herng Sheu, Jinxiu Shi, Xiao-Ou Shu, Megan M. Shuey, Moneeza K. Siddiqui, Jennifer A. Smith, Tamar Sofer, Cassandra N. Spracklen, Adrienne M. Stilp, Meng Sun, Yasuharu Tabara, E Shyong Tai, Salman M. Tajuddin, Atsushi Takahashi, Fumihiko Takeuchi, Jingyi Tan, Kent D. Taylor, Katherine Taylor, Farook Thameem, Lin Tong, Fuu‐Jen Tsai, Philip S. Tsao, Miriam S. Udler, Adán Valladares‐Salgado, David A. van Heel, Rob M. vanDam, Rohit Varma, Maheak Vora, Niels H. Wacher, Ya Xing Wang, Ellie Wheeler, Eric A. Whitsel, Ananda R. Wickremasinghe, Genevieve L. Wojcik, Tien Yin Wong, Jer‐Yuarn Wu, Yong-Bing Xiang, Anny H. Xiang, Chittaranjan S. Yajnik, Ken Yamamoto, Toshimasa Yamauchi, Lisa R. Yanek, Jie Yao, Mitsuhiro Yokota, Jian-Min Yuan, Salim Yusuf, Eleftheria Zeggini, Liang Zhang, Weihua Zhang, Wei Zheng, Alan B. Zonderman, Carlos A. Aguilar‐Salinas, Clicerio González‐Villalpando, Christopher A. Haiman, Young Jin Kim, Soo Heon Kwak, Aaron Leong, Ruth J. F. Loos, Andrés Moreno‐Estrada, Andrew P. Morris, Lorena Orozco, Jerome I. Rotter, Dharambir K. Sanghera, Teresa Tusié‐Luna, Benjamin F. Voight, Marijana Vujković, Robin Walters, Tian Ge, Marie Loh, Jennifer E. Below, Xueling Sim, Josep M. Mercader, Maggie C. Y. Ng

Bibliographic record

VenueThe Lancet Diabetes & Endocrinology · 2025
Typepreprint
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenetic Associations and Epidemiology
Canadian institutionsImpactMcGill UniversityHamilton Health SciencesUniversity of TorontoMcMaster UniversityPopulation Health Research Institute
FundersNational Center for Advancing Translational SciencesNational Human Genome Research InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteNational Institute on AgingManchester Biomedical Research CentreAmerican Diabetes AssociationNational Institute of Neurological Disorders and StrokeNational Institute for Health and Care ResearchNovo Nordisk UK Research FoundationNational Institutes of HealthU.S. Department of Health and Human ServicesFoundation for the National Institutes of Health
KeywordsPolygenic risk scoreType 2 diabetesComputational biologyGeneticsDemographyDiabetes mellitusMedicineBiologyGerontologyEvolutionary biologyGeneEndocrinologySingle-nucleotide polymorphismGenotypeSociology

Abstract

fetched live from OpenAlex

BACKGROUND: Polygenic risk scores (PRSs) improve prediction of the development of type 2 diabetes over the use of clinical risk factors alone; however, they perform poorly in populations of non-European ancestry, limiting their global clinical utility. We aimed to deliver comprehensive and rigorously tested multi-ancestry PRSs for prediction in type 2 diabetes. METHODS: We conducted meta-analyses using data from type 2 diabetes genome-wide association studies (GWAS) across cohorts from five major global ancestries: European, African or African American, Admixed American, South Asian, and East Asian. We used summary statistics from the GWAS to construct single-ancestry PRSs (using the continuous-shrinkage PRS-CS method) and multi-ancestry PRSs (using the PRS-CSx method), and constructed ancestry-specific linkage disequilibrium panels to model pairwise correlations between single-nucleotide polymorphisms in GWAS during PRS construction. Models were validated for association with type 2 diabetes in at least four independent cohorts per ancestry. The effect sizes of PRSs were estimated as the odds ratio (OR) per SD of the PRS, and ORs for individuals at the 90th, 95th, and 97·5th PRS percentiles were compared with the IQR as a reference. We also tested our PRS models for prediction of diabetes incidence with or without additional clinical factors, as well as microvascular complications and comorbidities. FINDINGS: Our analysis used data from 409 959 individuals with type 2 diabetes and 1 983 345 controls: respectively, 359 819 and 1 825 729 indivduals were included in the GWAS dataset, with 10 992 and 31 792 individuals in the training dataset and 39 148 and 125 824 individuals in the validation dataset. The best predictive performance for the single-ancestry PRSs was in European (incremental AUC 0·07-0·14) and East Asian (0·02-0·16) ancestries, whereas prediction was poorer for African or African American (0·02-0·03), Admixed American (0·02-0·04), and South Asian (0·02-0·04) ancestries, correlating with sample sizes in the GWAS. Compared with single-ancestry PRSs, our multi-ancestry PRSs showed higher effect sizes and smaller 95% CIs across all ancestries: OR per SD 1·73 (95% CI 1·67-1·80) in African or African American, 2·82 (2·67-2·97) in Admixed American, 2·45 (2·36-2·54) in East Asian, 2·36 (2·32-2·41) in European, and 2·23 (2·05-2·42) in South Asian ancestries. Individuals in the 97·5th PRS percentile had a 3-7 times increased risk of type 2 diabetes compared with those in the IQR (OR 3·43 [95% CI 2·80-4·21] in African or African American, 7·47 [5·64-9·89] in Admixed American, 6·62 [5·58-7·85] in East Asian, 6·25 [5·72-6·82] in European, and 4·50 [2·70-7·53] in South Asian ancestries). These PRSs were also associated with earlier onset of type 2 diabetes, higher risk of developing microvascular complications, and provide additional predictive value beyond clinical factors. In individuals with type 2 diabetes, the association between multi-ancestry PRSs and risk of microvascular complications and comorbidity was studied in populations of African, Admixed American, and European ancestries and was significant in all three ancestry groups for diabetic retinopathy (ORs per SD 1·28-1·57), diabetic nephropathy (1·25-1·58), proliferative diabetic retinopathy (1·39-2·08), and end-stage diabetic nephropathy (1·44-1·87); PRS was associated with coronary artery disease in the Admixed American ancestry group only (1·16 [95% CI 1·08-1·25]). INTERPRETATION: These validated, publicly available PRSs can improve risk stratification for type 2 diabetes onset and complications across diverse ancestries, supporting their further evaluation in clinical settings. FUNDING: The National Human Genome Research Institute of the US National Institutes of Health.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.023
metaresearch head score (Gemma)0.029
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.023
Threshold uncertainty score0.124

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0230.029
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.006
Bibliometrics0.0030.004
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.316
Teacher spread0.260 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Diabetes & EndocrinologySame topicGenetic Associations and EpidemiologyFrench-language works237,207